𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

✍ Scribed by Kornek, G V; Raderer, M; Schüll, B; Fiebiger, W; Gedlicka, C; Lenauer, A; Depisch, D; Schneeweiss, B; Lang, F; Scheithauer, W

Book ID
109997276
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
94 KB
Volume
86
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with granulocyt
Combination chemotherapy with granulocyte-macrophage–colony stimulating factor in patients with locoregional and metastatic gastric adenocarcinoma
✍ Susan Partyka; Pamela Dumas; Jaffer Ajani 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## BACKGROUND. A combination of etoposide, 5-fluorouracil, and folinic acid (ELF) remains popular for the treatment of patients with gastric carcinoma and has been reported to result in a response rate of up to 40% with good patient tolerance. The authors elected to add granulocyte-macrophage-colo

Phase I trial of paclitaxel, carboplatin
Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer
✍ John D. Hainsworth; Howard A. Burris III; Lisa H. Morrissey; F. Anthony Greco 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 3 views

## Background: Topotecan is a new antineoplastic agent with a broad spectrum of activity. the purpose of this phase i trial was to define the maximum tolerated dose of topotecan when added to the widely used combination of paclitaxel and carboplatin. ## Methods: Patients with advanced cancer that